Icosavax Inc (DELISTED) (ICVX:DL)
15.31
0.00 (0.00%)
USD |
NASDAQ |
Feb 29, 16:00
Icosavax Total Liabilities (Quarterly): 18.92M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 18.92M |
| June 30, 2023 | 21.30M |
| March 31, 2023 | 19.59M |
| December 31, 2022 | 20.52M |
| September 30, 2022 | 18.22M |
| June 30, 2022 | 17.25M |
| Date | Value |
|---|---|
| March 31, 2022 | 17.10M |
| December 31, 2021 | 9.409M |
| September 30, 2021 | 8.385M |
| June 30, 2021 | 158.01M |
| March 31, 2021 | 157.60M |
| December 31, 2020 | 42.87M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.385M
Minimum
Sep 2021
158.01M
Maximum
Jun 2021
42.43M
Average
19.25M
Median
Total Liabilities (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | 81.97M |
| Immunogen Inc (DELISTED) | 260.50M |
| AbbVie Inc | 140.83B |
| Assure Holdings Corp | 22.85M |
| Harpoon Therapeutics Inc (DELISTED) | 43.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 251.30M |
| Shareholders Equity (Quarterly) | 232.38M |